Sense Biodetection Limited is a molecular diagnostics company .
Sense Biodetection Limited is a molecular diagnostics company focused on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 20, 2021 | Series B | $50M | 1 | — | — | Detail |
| Oct 28, 2019 | Series A | £10.50M | 1 |
Cambridge Innovation Capital
|
— | Detail |
| Jul 20, 2016 | Seed | £500K | 1 |
Mercia Fund Managers
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Mercia Fund Managers
|
Yes | Seed |
Cambridge Innovation Capital
|
— | Series B |